G-BA decisions from 12 May 2023
Here are the G-BA decisions from the G-BA meeting held on 12 May 2023 on the early benefit assessments of Tezpire, Adtralza
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Here are the G-BA decisions from the G-BA meeting held on 12 May 2023 on the early benefit assessments of Tezpire, Adtralza
Here are the G-BA decisions from the G-BA meeting held on 20 April 2023 on the early benefit assessments of Ultomiris, Genvoya,
At the end of September 2022, the hospital commission suggested introducing flat day rates (German: “Tagespauschalen”) for hospital day treatments. Driven by
Since 2020, the G-BA can request real-world evidence data collection in Germany. However, so far this was only implemented for one product,
On Friday, 21 Oct 2022, the German House of Representatives has now finalized the law on the financial stabilization of statutory health